Yüklüyor......
New Therapies in Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with high rates of mortality and morbidity. Beginning with cetuximab, investigators continue to optimize antibody technology to target cell surface receptors that promote HNSCC growth. Small molecules and oligonucleotides have also...
Kaydedildi:
| Yayımlandı: | Trends Cancer |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226306/ https://ncbi.nlm.nih.gov/pubmed/29709262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2018.03.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|